Comparison
1q44 Microdeletion Syndrome C4304540 vs 13q12 3 Microdeletion Syndrome C4750951
Clinical comparison between 1q44 Microdeletion Syndrome and 13q12 3 Microdeletion Syndrome for differential diagnosis and treatment planning.
1q44 Microdeletion Syndrome C4304540
A rare chromosomal abnormality affecting chromosome 1. Causes developmental delays, intellectual disability, and brain abnormalities. Management is supportive and symptom-focused.
13q12 3 Microdeletion Syndrome C4750951
A rare genetic condition where a small piece of chromosome 13 is missing. It can cause various developmental and medical concerns. Care is supportive and tailored to the individual's needs.
6 comparison axes
Onset
1q44 Microdeletion Syndrome C4304540
0-null
13q12 3 Microdeletion Syndrome C4750951
0-null
Onset patterns differ
Severity
1q44 Microdeletion Syndrome C4304540
severe
13q12 3 Microdeletion Syndrome C4750951
moderate
Different severity levels
Chronic
1q44 Microdeletion Syndrome C4304540
Chronic
13q12 3 Microdeletion Syndrome C4750951
Chronic
Differing course
Communicable
1q44 Microdeletion Syndrome C4304540
No
13q12 3 Microdeletion Syndrome C4750951
No
Different transmission
Body System
1q44 Microdeletion Syndrome C4304540
congenital
13q12 3 Microdeletion Syndrome C4750951
congenital
Same/different system
Category
1q44 Microdeletion Syndrome C4304540
rare-disease
13q12 3 Microdeletion Syndrome C4750951
genetic
Different category
Bottom line
1q44-microdeletion-syndrome-C4304540 and 13q12-3-microdeletion-syndrome-C4750951 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 1q44 Microdeletion Syndrome C4304540 | 13q12 3 Microdeletion Syndrome C4750951 | Discriminating power |
|---|---|---|---|
| Chromosomal locus | Involves a microdeletion at chromosome 1q44. | Involves a microdeletion at chromosome 13q12.3. | High |
| Described developmental pattern | Source links it to developmental delay, intellectual disability, and brain abnormalities. | Source describes varied developmental and medical concerns without a fixed pattern. | Moderate |
| Recorded severity | Categorized as severe in the supplied record. | Categorized as moderate in the supplied record. | Low |
When to favor each condition
Choose 1q44 Microdeletion Syndrome C4304540 when
Confirmed copy-number loss at 1q44
The chromosomal locus directly matches this diagnosis.
High
Developmental delay with reported brain abnormality
This fits the supplied phenotype, but genetic confirmation is still required.
Moderate
Counseling for a chromosome 1 finding
Use this label only after laboratory review of breakpoints and clinical correlation.
Moderate
Choose 13q12 3 Microdeletion Syndrome C4750951 when
Confirmed copy-number loss at 13q12.3
The chromosomal locus directly matches this diagnosis.
High
Variable developmental concerns without a specified pattern
This is compatible with the sparse source description but is not diagnostic alone.
Low
Counseling for a chromosome 13 finding
Apply this label only after clinician and laboratory interpretation.
Moderate
How key tests differ
| Test | 1q44 Microdeletion Syndrome C4304540 | 13q12 3 Microdeletion Syndrome C4750951 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | Copy-number loss involving 1q44. | Copy-number loss involving 13q12.3. | The locus distinguishes them; pathogenicity and breakpoints need specialist review. |
| Standard karyotype | A small deletion may not be visible. | A small deletion may not be visible. | A normal karyotype does not exclude either condition. |
| Clinical and imaging assessment | Brain abnormalities are described but not universally defined here. | Specific imaging findings are not established in the source. | Phenotype guides evaluation; it does not replace genetic confirmation. |
Prognosis comparison
1q44 Microdeletion Syndrome C4304540
- Outcome
- Chronic course with potentially substantial developmental impact; precise outcome is not established.
- Factors
- Severity label, developmental findings, brain abnormalities, and deletion details may matter.
13q12 3 Microdeletion Syndrome C4750951
- Outcome
- Chronic course with potentially moderate, variable impact; precise outcome is not established.
- Factors
- Individual developmental and medical findings and deletion details may matter.
Time frame: Lifelong congenital condition; exact onset timing is not established.
Clinician interpretation should consider breakpoints, associated findings, and available supports.
Complications comparison
| Complication | Presentation |
|---|---|
| Neurodevelopmental complications | Developmental delay and intellectual disability are described. Developmental concerns are possible but not specifically defined. Individual severity and complications require clinical assessment. |
| Structural brain findings | Brain abnormalities are mentioned in the source. No specific structural complication is established here. Imaging results must be interpreted by the treating clinician. |
| Other medical complications | Additional complications are not established from the supplied data. Medical concerns may vary, but exact complications are unspecified. Do not infer organ-specific risks without source evidence. |
Patient education highlights
- HighDiagnosis
The specific deleted chromosomal region, not symptoms alone, distinguishes these conditions.
- HighCare
Both generally require supportive, individualized care; no treatment dose is established here.
- MediumUncertainty
Reported severity differs, but prognosis and exact complications are not established from these data.